Trial · NCT07900919
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Uterine tone-obstetrician evaluation scores | up to 2 hours | measured by 0-10 numeric rating scale (0 = atonic, 10 = firm/optimal), assessed by obstetrician blinded to group, at fixed timepoints (2, 5, 10 minutes after delivery) - higher scores denoting more desirable |
| Primary | Change in Uterine tone-obstetrician evaluation scores with Uterine tone-uterotonic drug administration | up to 2 hours | measured by 0-10 numeric rating scale (0 = atonic, 10 = firm/optimal), assessed by obstetrician blinded to group, at fixed timepoints (2, 5, 10 minutes after delivery) - higher scores denoting more desirable - measured by addition of supplemental uterotonics - methylergonivine, carboprost, misoprostol, total amount of oxytocin over 20 minutes post delivery |
| Primary | Uterine tone-blood loss amount | hour 24 | Quantitative blood loss (QBL) via gravimetric sponge/lap weighing plus calibrated suction canister volume, corrected for irrigation fluid |
| Primary | Uterine tone-blood loss amount - Postoperative hemoglobin drop | hour 24 | Quantitative blood loss (QBL) Postoperative hemoglobin drop (pre-op minus postoperative day 1 hemoglobin) |
| Secondary | Incidence of Hypotension | up to 2 hours | systolic blood pressure \<80% baseline |
| Secondary | Incidence of Bradycardia | up to 2 hours | heart rate \<60bpm |
| Secondary | Number of rescue boluses of vasopressor | up to 2 hours | number of rescue bolus doses of vasopressors used |
| Secondary | Nausea | up to 2 hours | presence or absence of nausea occurring |
| Secondary | Intraoperative nausea/vomiting (yes/no) | up to 2 hours | presence or absence of vomiting occurring |
| Secondary | umbilical blood gas | up to 2 hours | if done, measurement of pH, base excess, and lactate |
| Secondary | Fetal Apgar scores | Minute 1 and 5 | measurement of Apgar scores at minutes 1 and 5 after birth * 7 to 10: Normal and healthy; the baby is doing well. * 4 to 6: Fairly low; the baby might need some help breathing or warming up. * 3 or lower: Critically low; the baby needs immediate medical care or life-saving help |
| Secondary | Incidence of Postpartum hemorrhage | Hour 24 | incidence of postpartum hemorrhage and if transfusion or other blood product derivative required |
| Secondary | Incidence of Maternal Shivering | up to 2 hours | incidence of shivering occurring -yes or no |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07900919/registered